MENTICE AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.6 SEK | -0.84% |
|
-6.81% | -25.37% |
| Apr. 02 | Mentice Receives an Order of USD 795,000 for Development Services from A World-Leading Medtech Company | CI |
| Mar. 21 | Transcript : Mentice AB - Analyst/Investor Day |
Presenter SpeechChristian Binder (Analysts)Hi, and welcome, everyone. Mentice recently reporte...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Mentice AB is a Sweden-based medical technology company. It provides software and hardware simulation solutions and related services for endovascular therapies. The Companyâs solutions help healthcare professionals acquire, retain, and enhance their procedural skills. The Companyâs solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. The Company also covers neurovascular, cardiovascular and peripheral interventions, among others. It is active globally.
Calendar
2024-05-03
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.9
SEK
Average target price
55.33
SEK
Spread / Average Target
+54.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -25.37% | 83.99M | |
| +72.92% | 12.36B | |
| -19.68% | 7.83B | |
| +16.20% | 7.21B | |
| +4.77% | 5.97B | |
| +7.49% | 5.14B | |
| +23.97% | 4.43B | |
| -18.81% | 3.9B | |
| -41.54% | 2.2B | |
| +1.61% | 2.02B |
- Stock Market
- Equities
- MNTC Stock
- News Mentice AB
- Transcript : Mentice AB, H1 2023 Earnings Call, Jul 20, 2023
